Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Manish M, Patel"'
Autor:
Shreya Chodisetty, Manish M. Patel, Eric J Chow, Katherine Adams, Benjamin Lee, Mark W Tenforde, Wesley H. Self
Publikováno v:
Hum Vaccin Immunother
Influenza vaccination and antiviral therapeutics may attenuate disease, decreasing severity of illness in vaccinated and treated persons. Standardized assessment tools, definitions of disease severity, and clinical endpoints would support characteriz
Autor:
Monica N Singer, Leila C. Sahni, Angela P Campbell, Christopher J. Harrison, Flor M. Munoz, Julie A. Boom, Parvin H. Azimi, Janet A. Englund, Rangaraj Selvarangan, Monica M. McNeal, Herdi Rahman, Peter G. Szilagyi, Lubna Hamdan, Mary A. Staat, Natasha B. Halasa, Andrew J. Spieker, Laura S Stewart, Geoffrey A. Weinberg, Simon N. Vandekar, John V. Williams, Zaid Haddadin, Manish M. Patel, Eileen J. Klein, Varvara Probst
Publikováno v:
Influenza and Other Respiratory Viruses. 16:289-297
Antiviral treatment is recommended for all hospitalized children with suspected or confirmed influenza, regardless of their risk profile. Few data exist on adherence to these recommendations, so we sought to determine factors associated with influenz
Autor:
Anne Zepeski, Catherine L. Hough, Wesley H. Self, Ian Jones, Amira Mohamed, Tresa McNeal, Samuel M. Brown, Shekhar Ghamande, Jennifer G. Wilson, Alexandra June Gordon, Eric A. Naioti, Manjusha Gaglani, Jay S. Steingrub, Steven Y. Chang, Natalie J. Thornburg, Yuwei Zhu, Adrienne Baughman, Mark W Tenforde, Matthew E. Prekker, Christopher J. Lindsell, William B. Stubblefield, Arnold S. Monto, Nida Qadir, James D. Chappell, Nicholas M. Mohr, Carolina Rivas, Sandra N. Lester, Abhijit Duggal, Ithan D. Peltan, Kevin W Gibbs, Jillian P. Rhoads, Jennifer R. Verani, Miwako Kobayashi, Hilary M. Babcock, Manish M. Patel, Arber Shehu, Emily T. Martin, Natasha B. Halasa, Laurence W. Busse, Megan M. Stump, Jennie H. Kwon, David J. Douin, Daniel J. Henning, Matthew C. Exline, Kelsey N Womack, Michelle N. Gong, Todd W. Rice, Samantha M. Olson, H. Keipp Talbot, Adam S. Lauring, Jonathan D Casey, Adit A. Ginde, Kimberly W. Hart, Heidi L Erickson, D. Clark Files, David N. Hager, Carlos G. Grijalva, Lisa Mills, Christopher Mallow, Akram Khan, Caitlin C Ten Lohuis
Publikováno v:
Morbidity and Mortality Weekly Report
Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug Ad
Autor:
Manish M. Patel, Shekhar Ghamande, Jill M. Ferdinands, Manjusha Gaglani, Kempapura Murthy, Courtney Shaver, Richard K. Zimmerman, Dayna Wyatt, Fernanda P. Silveira, Arnold S. Monto, Emily T. Martin, Chandni Raiyani, Alejandro C. Arroliga, Donald B Middleton, Tasnim Lat, H. Keipp Talbot, Heath D White
Publikováno v:
Clin Infect Dis
BackgroundEvidence for vaccine effectiveness (VE) against influenza-associated pneumonia has varied by season, location, and strain. We estimate VE against hospitalization for radiographically identified influenza-associated pneumonia during 2015–2
Autor:
Huong Q. McLean, Brendan Flannery, Ivo M. Foppa, Jessie R Chung, Emily T. Martin, Edward A. Belongia, Goundappa K. Balasubramani, Michael L. Jackson, Kempapura Murthy, Manish M. Patel, Lisa A. Jackson, Richard K. Zimmerman, Arnold S. Monto, Manjusha Gaglani, Eric P. Griggs
Publikováno v:
Am J Epidemiol
Intraseason timing of influenza infection among persons of different ages could reflect relative contributions to propagation of seasonal epidemics and has not been examined among ambulatory patients. Using data from the US Influenza Vaccine Effectiv
Autor:
Donald B Middleton, Manish M. Patel, Shekhar Ghamande, Christopher Trabue, Samantha M. Olson, Kempapura Murthy, Jill M. Ferdinands, Fernanda P. Silveira, Arnold S. Monto, Manjusha Gaglani, Emily T. Martin, Joshua G. Petrie, Richard K. Zimmerman, H. Keipp Talbot
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Novel coronavirus disease 2019 (COVID-19) is frequently compared with influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducts studies on the etiology and characteristics of U.S. hospitalized adults with
Autor:
Carlos G. Grijalva, Michelle N. Gong, Todd W. Rice, Matthew E. Prekker, Adrienne Baughman, Samuel K. Nwosu, Manish M. Patel, Jay S. Steingrub, Ithan D. Peltan, Nathan I. Shapiro, Matthew C. Exline, Leora R. Feldstein, Kevin W Gibbs, Christopher J. Lindsell, Natasha B. Halasa, William B Stubblefield, H. Keipp Talbot, Michael S. Aboodi, Heidi L Erickson, Akram Khan, Mark W Tenforde, D. Clark Files, Wesley H. Self, Jonathan D Casey, Adit A. Ginde, Samuel M. Brown
Publikováno v:
Clin Infect Dis
Background Influenza vaccine effectiveness (VE) against a spectrum of severe disease, including critical illness and death, remains poorly characterized. Methods We conducted a test-negative study in an intensive care unit (ICU) network at 10 US hosp
Autor:
Matthew E. Prekker, Nathan I. Shapiro, Michelle N. Gong, Todd W. Rice, Samuel M. Brown, Adrienne Baughman, Jill M. Ferdinands, Kevin W Gibbs, Ithan D. Peltan, Christopher J. Lindsell, Manish M. Patel, D. Clark Files, H. Keipp Talbot, Matthew C. Exline, Leora R. Feldstein, Carlos G. Grijalva, Margaret M Newhams, Jay S. Steingrub, Akram Khan, Wesley H. Self, Michael S. Aboodi, Adrienne G. Randolph, Adit A. Ginde, M. Elizabeth Halloran, Natasha B. Halasa
Publikováno v:
J Infect Dis
Background Test-negative design studies for evaluating influenza vaccine effectiveness (VE) enroll patients with acute respiratory infection. Enrollment typically occurs before influenza status is determined, resulting in over-enrollment of influenza
Autor:
Manish M. Patel, Richard K. Zimmerman, Fernanda P. Silveira, Donald B Middleton, Arnold S. Monto, H. Keipp Talbot, Emily T. Martin, Jill M. Ferdinands, Manjusha Gaglani
Publikováno v:
Clin Infect Dis
We observed decreased effectiveness of influenza vaccine with increasing time since vaccination for prevention of influenza A(H3N2), influenza A(H1N1)pdm09, and influenza B/Yamagata–associated hospitalizations among adults. Maximum vaccine effectiv
Autor:
Fernanda P. Silveira, Amelia Drennan, Rebecca Kondor, Manjusha Gaglani, Shoshona Le, Richard K. Zimmerman, Briana Krantz, Kailey Hughes, Adam S. Lauring, Bethany Alicie, Yuwei Zhu, Arnold S. Monto, Arundhati Rao, Manish M. Patel, K G Balasubramani, Joshua G. Petrie, Heath White, Christopher Trabue, Manohar Mutnal, Donald B Middleton, Nicole Wheeler, Mark W Tenforde, Karen Speer, Lisa M Keong, Thomas J. Stark, Sean G Saul, Lori Stiefel, Kevin Chang, Jill M. Ferdinands, Ryan E. Malosh, Mohamed Yassin, Shekhar Ghamande, Emily T. Martin, Chandni Raiyani, Rendi McHenry, Natasha B. Halasa, Jan Orga, Kelsey Bounds, Tresa McNeal, John W Williams, Donna Carillo, Lydia Clipper, Lois Lamerato, Heather Eng, Alejandro Arroliga, Mary Patricia Nowalk, H. Keipp Talbot, Claudia Guevara Pulido, Dayna Wyatt, Emily Sedillo, Alina Simion, Tnelda Zunie, Zhouwen Liu, Kempapura Murthy, Laura Adams, Stephanie Longmire, John Barnes, Juliana Almeida da Silva, Anurag Malani, Kellie Graves, Samantha M Olson, Lynn Peterson
Publikováno v:
J Infect Dis
Background Influenza causes significant morbidity and mortality and stresses hospital resources during periods of increased circulation. We evaluated the effectiveness of the 2019–2020 influenza vaccine against influenza-associated hospitalization